🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is aimed to evaluate the efficacy and safety of Apatinib and MASC...
Status
Unknown
Location
The First's People Hospital of Lianyungang
Start Date
2016-07
Trial ID
NCT02844881
Crohn's Disease (CD) is an inflammatory bowel disease. It can lead to signi...
Status
Recruiting
Location
Icahn School of Medicine at Mount Sinai
Start Date
2018-02-22
Trial ID
NCT03219359
Neoantigen （Neo）is a new targets for immune cells，that the DC neoantigen im...
Status
Unknown
Location
Xiaodong Jiang
Start Date
2017-08
Trial ID
NCT03205930
Treatments Being Tested
The purpose of this study is to evaluate Safety and tolerability of MASCT-I...
Status
Terminated
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2017-02-22
Trial ID
NCT03034304
Treatments Being Tested
Multiple Target Antigen Stimulating Cell Therapy (MASCT-I) is a new immunot...
Status
Unknown
Location
Multiple Locations
Start Date
2016-08
Trial ID
NCT02858232
Treatments Being Tested
This study will evaluate the safety and efficacy of MASCT-I combined with D...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-02-21
Trial ID
NCT06277154
Treatments Being Tested
This study will evaluate the safety and preliminary efficacy of Multi-Antig...
Status
Unknown
Location
Shanghai Sixth People's Hospital
Start Date
2019-11-22
Trial ID
NCT04074564
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of MAS...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2020-04-21
Trial ID
NCT05877651
Treatments Being Tested
To prove that the efficacy and safety of 'MASCT group' is superior to 'non-...
Status
Suspended
Location
JOE ZHOU
Start Date
2013-07
Trial ID
NCT02026362
This study evaluate the safety and tolerance of MASCT-I(multiple-antigen sp...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2018-04-19
Trial ID
NCT03393416
Treatments Being Tested